Theodora Karagounis is a Dermatology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 First Avenue
Nyu Langone Medical Center
New York, NY 10016
Telephone
212-263-5250Provider last certified this registry record 29 Aug 2022.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Janssen Biotech, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
35.3%Azole Antifungal35.3%Ketoconazole100%Part D≥16 patientsDermatology
29.4%Corticosteroid18.6%Triamcinolone Acetonide100%Part D≥13 patientsAntivirals10.8%Imiquimod100%Part D<11 patientsCancer & immunology
21.6%Calcineurin inhibitor21.6%Tacrolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Contributions of gastrointestinal Staphylococcus aureus and other gut microbiota to pediatric atopic dermatitis
New York University School of Medicine
FY2026$172,005K08AR084045 - Contributions of gastrointestinal Staphylococcus aureus and other gut microbiota to pediatric atopic dermatitis
New York University School of Medicine
FY2025$172,005K08AR084045 - Contributions of gastrointestinal Staphylococcus aureus and other gut microbiota to pediatric atopic dermatitis
New York University School of Medicine
FY2024$172,005K08AR084045
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”